CERS Q2 2020 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$335M

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$22M+18.1% YoY

Gross Profit

$12M54.9% margin

Operating Income

-$15M-67.9% margin

Net Income

-$15M-69.2% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

+15.5%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$215M

Total Liabilities

$101M

Stockholders' Equity

$115M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$18M	+18.1%
Gross Profit	$12M	$10M	+16.8%
Operating Income	-$15M	-$17M	+13.0%
Net Income	-$15M	-$18M	+15.3%

Revenue Segments

Government Contract

$5M100%

Geographic Segments

Europe Middle East And Africa

$14M67%

North America

$6M30%

Other

$641,0003%